Image source: GW Pharmaceuticals plc.
What: Ahead of important data that may add conviction to the use of marijuana to treat epilepsy patients, shares in GW Pharmaceuticals plc (NASDAQ: GWPH) soared 18.7% last month, according to S&P Global Market Intelligence.